Celldex Therapeutics
CLDX
#5280
Rank
HK$8.74 B
Marketcap
HK$131.81
Share price
-6.67%
Change (1 day)
-59.55%
Change (1 year)

Celldex Therapeutics (CLDX) - P/B ratio

P/B ratio as of April 2025 : 1.51

According to Celldex Therapeutics's latest financial reports the company has a price-to-book ratio of 160.995.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Celldex Therapeutics - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.25-55.38%
2023-12-315.05-21.47%
2022-12-316.4449.5%
2021-12-314.3029.88%
2020-12-313.31723.36%
2019-12-310.402540.68%
2018-12-310.2861-82.49%
2017-12-311.6321%
2016-12-311.35-74.68%
2015-12-315.33-30.95%
2014-12-317.7214.34%
2013-12-316.7649.84%
2012-12-314.51169.96%
2011-12-311.67-4.83%
2010-12-311.75-12.51%
2009-12-312.01-70.91%
2008-12-316.90-121.04%
2007-12-31-32.8-170.71%
2006-12-3146.3594.29%
2005-12-316.6772.05%
2004-12-313.88-38.91%
2003-12-316.35190.68%
2002-12-312.18

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
16.9 1,018.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.1301-108.60%๐Ÿ‡บ๐Ÿ‡ธ USA
0.5413-64.22%๐Ÿ‡บ๐Ÿ‡ธ USA
28.2 1,762.18%๐Ÿ‡บ๐Ÿ‡ธ USA
1.58 4.44%๐Ÿ‡บ๐Ÿ‡ธ USA
4.71 211.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.40-7.38%๐Ÿ‡บ๐Ÿ‡ธ USA